The global Beta-Thalassemia Market is expected to reach USD 823.1 million by 2030, at a CAGR of 8% during the forecast period 2021 to 2030. Over the next few years, the market is expected to grow because more people around the world will have beta-thalassemia. For example, a global biopharmaceutical company called Bristol-Myers Squibb Company put out a report in November 2018 saying that about 1.5% of the world's population, or between 80 and 90 million people, carry the beta-thalassemia gene. Even though beta-thalassemia is not very common in the United States, it is thought that 1.25 million people, or 0.4% of the population, are carriers. Also, the same source says that there are about 2,000 people in the United States who have thalassemia, and 1,000 of these people have -thalassemia major.